SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-042849
Filing Date
2018-08-08
Accepted
2018-08-08 16:32:11
Documents
66
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv499317_10q.htm 10-Q 448060
2 EXHIBIT 31.1 tv499317_ex31-1.htm EX-31.1 10026
3 EXHIBIT 31.2 tv499317_ex31-2.htm EX-31.2 9906
4 EXHIBIT 32.1 tv499317_ex32-1.htm EX-32.1 3921
5 EXHIBIT 32.2 tv499317_ex32-2.htm EX-32.2 3816
  Complete submission text file 0001144204-18-042849.txt   5395304

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nvax-20180630.xml EX-101.INS 1623860
7 XBRL TAXONOMY EXTENSION SCHEMA nvax-20180630.xsd EX-101.SCH 33816
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvax-20180630_cal.xml EX-101.CAL 35020
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvax-20180630_def.xml EX-101.DEF 248639
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20180630_lab.xml EX-101.LAB 312685
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20180630_pre.xml EX-101.PRE 287325
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 181001848
SIC: 2836 Biological Products, (No Diagnostic Substances)